Murky sales report imo Why dont they break down the sales report with the end demand from partients and variations (plus or minus) in inventories in the sales channels
Gloating over 49% increase in Egrifta sales where most of the increase it seems is purely inventory replesnisment .....Why keep everybody guessing by not providing exact metrics
They have covered their behind by adding"
moving forward we expect sales to align with patient demand now that inventory levels have returned to normal"
Not man enough to be fully transparent .....
I am open to hearing arguments proving that I am reading this wrong